Does PEGFILGRASTIM Cause Breast cancer? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Breast cancer have been filed in association with PEGFILGRASTIM (ZIEXTENZO). This represents 0.1% of all adverse event reports for PEGFILGRASTIM.
42
Reports of Breast cancer with PEGFILGRASTIM
0.1%
of all PEGFILGRASTIM reports
6
Deaths
11
Hospitalizations
How Dangerous Is Breast cancer From PEGFILGRASTIM?
Of the 42 reports, 6 (14.3%) resulted in death, 11 (26.2%) required hospitalization, and 2 (4.8%) were considered life-threatening.
Is Breast cancer Listed in the Official Label?
Yes, Breast cancer is listed as a known adverse reaction in the official FDA drug label for PEGFILGRASTIM.
What Other Side Effects Does PEGFILGRASTIM Cause?
Device adhesion issue (11,326)
Wrong technique in product usage process (10,217)
Unintentional medical device removal (8,882)
Device malfunction (6,818)
Device use error (6,001)
Device issue (5,071)
Accidental exposure to product (4,967)
Device occlusion (3,239)
Off label use (3,228)
Bone pain (2,266)
What Other Drugs Cause Breast cancer?
RANITIDINE (45,666)
LETROZOLE (1,393)
ETANERCEPT (1,303)
METHOTREXATE (936)
ADALIMUMAB (894)
INFLIXIMAB (789)
RIBOCICLIB (788)
FULVESTRANT (684)
DENOSUMAB (671)
ABATACEPT (617)
Which PEGFILGRASTIM Alternatives Have Lower Breast cancer Risk?
PEGFILGRASTIM vs PEGFILGRASTIM-APGF
PEGFILGRASTIM vs PEGFILGRASTIM-BMEZ
PEGFILGRASTIM vs PEGFILGRASTIM-CBQV
PEGFILGRASTIM vs PEGFILGRASTIM-JMDB
PEGFILGRASTIM vs PEGINTERFERON ALFA